Mefenamic acid and Temazepam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mefenamic acid (mefenamic acid) and Temazepam (temazepam). Common drug interactions include aortic aneurysm among females and coronary artery occlusion among males.

The phase IV clinical study analyzes what interactions people have when they take Mefenamic acid and Temazepam. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Mefenamic acid?

Mefenamic acid has active ingredients of mefenamic acid. It is often used in painful menstrual periods. eHealthMe is studying from 4,844 Mefenamic acid users. Check the latest studies of Mefenamic acid.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,106 Temazepam users. Check the latest studies of Temazepam.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

45 people who take Mefenamic acid and Temazepam together, and have interactions are studied.

Mefenamic acid and Temazepam drug interactions.

What are the common drug interactions of Mefenamic Acid and Temazepam, by gender? *:

female:

  1. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Head injury
  6. Headache (pain in head)
  7. Hunger
  8. Sedation
  9. Therapeutic response unexpected
  10. Upper-airway cough syndrome

male:

  1. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  2. Post procedural complication
  3. Blood pressure increased
  4. Cardiac disorder

What are the common drug interactions of Mefenamic Acid and Temazepam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  2. Depression
  3. Suicidal ideation

40-49:

  1. Depression
  2. Affect lability (emotional incontinence)
  3. Anxiety
  4. Asthenia (weakness)
  5. Back pain
  6. Breast cancer
  7. Dizziness
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Dysphoria (generalized dissatisfaction with life)
  10. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Infection
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Nausea (feeling of having an urge to vomit)
  4. Retching (strong involuntary effort to vomit)
  5. Visual acuity reduced (reduced clearness of vision)
  6. Weight decreased
  7. Asthenia (weakness)
  8. Death
  9. Drug intolerance (drug sensitivity)
  10. Eating disorder

60+:

  1. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  2. Post procedural complication
  3. Pneumonia

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 26 people, 57.78%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 33.33%
  3. Sleep Disorder: 11 people, 24.44%
  4. Pain: 10 people, 22.22%
  5. Stress And Anxiety: 8 people, 17.78%
  6. High Blood Pressure: 7 people, 15.56%
  7. Erection Problems: 6 people, 13.33%
  8. Hypotonia (low muscle tone): 6 people, 13.33%
  9. High Blood Cholesterol: 6 people, 13.33%
  10. Depression: 4 people, 8.89%

* Approximation only. Some reports may have incomplete information.

Do you take Mefenamic acid and Temazepam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mefenamic acid and Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mefenamic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mefenamic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mefenamic acid and temazepam (the active ingredients of Mefenamic acid and Temazepam, respectively), and Mefenamic acid and Temazepam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: